F-group (family)

140.1.1.5 Anticodon_1

Ligands and drugs

1,662
Member domains
45
with ligand contacts (≤ 4 Å)
2.7% of members
27
with DrugDomain annotations
1.6% of members
17
with a DrugBank compound
1.0% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

Chemical profiles are computed for X-groups. 140.1.1.5 belongs to X-group 140 Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases, which binds 6.8 ligand superclasses per 20 proteins, narrower than 63% of the 256 X-groups with enough proteins to compare. View its chemical profile →

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00410MRCMupirocin6
DB02916LMS[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate3
DB00167—Isoleucine2
DB00131AMPAdenosine phosphate1
DB00161—Valine1
DB01755ILAN-[Isoleucinyl]-N'-[adenosyl]-diaminosufone1

Most frequently bound compounds

PDB ligandNameDomains in contact
MRCMUPIROCIN8
ILAN-[ISOLEUCINYL]-N'-[ADENOSYL]-DIAMINOSUFONE6
LMS[(2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXYTETRAHYDRO-2-FURANYL]METHYL SULFAMATE4
LSS5'-O-(L-leucylsulfamoyl)adenosine4
VAAN-[VALINYL]-N'-[ADENOSYL]-DIAMINOSUFONE4
TARD(-)-TARTARIC ACID3
GV6[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] (2S,3S)-2-azanyl-3-methyl-pentanoate2
LImetalLITHIUM ION2
MGmetalMAGNESIUM ION2
AMPADENOSINE MONOPHOSPHATE1
CLCHLORIDE ION1
GVU(2E,4S,5S,6E,8E)-10-[(2S,3R,6S,8R,9S)-3-butyl-9-methyl-2-[(1E,3E)-3-methyl-5-oxidanyl-5-oxidanylidene-penta-1,3-dienyl]-3-(4-oxidanyl-4-oxidanylidene-butanoyl)oxy-1,7-dioxaspiro[5.5]undecan-8-yl]-4,8-dimethyl-5-oxidanyl-deca-2,6,8-trienoic acid1
IODIODIDE ION1
TLAL(+)-TARTARIC ACID1
WN9[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] (2S)-2-azanyl-3-methyl-butanoate1